Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC2 | Q92769 | 2/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 4/20 | 0.33 |
| ▸ | PPARA | Q07869 | 4/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2721276 | 0.86 | CHRM1 (0.37) | HDAC2CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL9632890 | 0.86 | GPR84 (0.42) | HDAC2TSHR | |
| SCHEMBL15390196 | 0.81 | CHRM1 (0.33) | HDAC2CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL4028046 | 0.80 | CHRM1 (0.38) | HDAC2CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL443490 | 0.79 | PPARG (0.46) | HDAC2CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL6786243 | 0.78 | HCAR2 (0.32) | HDAC2CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL7192903 | 0.77 | CHRM1 (0.35) | HDAC2CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL5165058 | 0.76 | HCAR2 (0.31) | TDP1 | |
| SCHEMBL2690161 | 0.76 | CA2 (0.38) | TSHR | |
| SCHEMBL4587180 | 0.76 | CHRM1 (0.34) | HDAC2CHRM1AKR1A1CHRM3HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7696257-B2 | Oxime ester compound and photopolymerization initiator containing such compound | ADEKA CORPORATION (JP) | 2010-04-13 | — | — | US | disclosed |
| US-20070270522-A1 | Oxime Ester Compound and Photopolymerization Initiator Containing Such Compound | ADEKA CORPORATION (JP) | 2007-11-22 | — | — | US | disclosed |
| EP-1489410-A2 | Copolymers for membranes in extended use planar sensors | Novartis AG (CH) | 2004-12-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070270522-A1 | Oxime Ester Compound and Photopolymerization Initiator Containing Such Compound | CBR3, CBR1, SCLY | HDAC2 3699/4885CHRM1 462/4885AKR1A1 219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.